Rossari Biotech [ROSSARI] vs Fineotex Chemical [FCL] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Rossari Biotech Ltd. wins in 9 metrics, Fineotex Chemical Ltd. wins in 10 metrics, with 1 ties. Fineotex Chemical Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Rossari Biotech Ltd. | Fineotex Chemical Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 20.79 | 26.19 | Rossari Biotech Ltd. |
| Price-to-Book Ratio | 2.28 | 3.39 | Rossari Biotech Ltd. |
| Debt-to-Equity Ratio | 28.18 | 0.00 | Tie |
| PEG Ratio | -2.83 | -0.29 | Fineotex Chemical Ltd. |
| EV/EBITDA | 12.22 | 22.94 | Rossari Biotech Ltd. |
| Profit Margin (TTM) | 6.01% | 16.79% | Fineotex Chemical Ltd. |
| Operating Margin (TTM) | 8.47% | 17.15% | Fineotex Chemical Ltd. |
| EBITDA Margin (TTM) | 8.47% | 17.15% | Fineotex Chemical Ltd. |
| Return on Equity | 11.50% | 14.65% | Fineotex Chemical Ltd. |
| Return on Assets (TTM) | 7.19% | 13.28% | Fineotex Chemical Ltd. |
| Free Cash Flow (TTM) | $-210.69M | $17.57M | Fineotex Chemical Ltd. |
| Dividend Yield | 6.54% | 0.64% | Rossari Biotech Ltd. |
| 1-Year Return | -25.68% | 47.31% | Fineotex Chemical Ltd. |
| Price-to-Sales Ratio (TTM) | 1.25 | 4.64 | Rossari Biotech Ltd. |
| Enterprise Value | $31.35B | $26.07B | Rossari Biotech Ltd. |
| EV/Revenue Ratio | 1.37 | 4.51 | Rossari Biotech Ltd. |
| Gross Profit Margin (TTM) | 31.10% | 35.24% | Fineotex Chemical Ltd. |
| Revenue per Share (TTM) | $414 | $5 | Rossari Biotech Ltd. |
| Earnings per Share (Diluted) | $24.84 | $0.88 | Rossari Biotech Ltd. |
| Beta (Stock Volatility) | 0.33 | 0.05 | Fineotex Chemical Ltd. |
Rossari Biotech Ltd. vs Fineotex Chemical Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Rossari Biotech Ltd. | 1.50% | -0.07% | 0.96% | 17.87% | -11.82% | -11.68% |
| Fineotex Chemical Ltd. | 5.95% | 8.81% | 63.13% | 94.38% | 69.18% | 69.04% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Rossari Biotech Ltd. | -25.68% | -40.58% | -58.57% | -31.08% | -31.08% | -31.08% |
| Fineotex Chemical Ltd. | 47.31% | 27.34% | 341.60% | 1,175.90% | 1,559.75% | 1,559.75% |
Performance & Financial Health Analysis: Rossari Biotech Ltd. vs Fineotex Chemical Ltd.
| Metric | ROSSARI | FCL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹28.60B | ₹27.02B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 230,277 | 4,015,706 |
| 90 Day Avg. Volume | 146,212 | 2,688,584 |
| Last Close | ₹511.50 | ₹41.50 |
| 52 Week Range | ₹375.00 - ₹766.00 | ₹19.10 - ₹44.44 |
| % from 52W High | -33.22% | -6.62% |
| All-Time High | ₹1,619.00 (Oct 11, 2021) | ₹458.85 (Feb 19, 2024) |
| % from All-Time High | -68.41% | -90.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.13% | 0.46% |
| Quarterly Earnings Growth | 0.03% | -0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.17% |
| Operating Margin (TTM) | 0.08% | 0.17% |
| Return on Equity (TTM) | 0.12% | 0.15% |
| Debt to Equity (MRQ) | 28.18 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹226.03 | ₹6.81 |
| Cash per Share (MRQ) | ₹13.87 | ₹0.55 |
| Operating Cash Flow (TTM) | ₹440.09M | ₹1.05B |
| Levered Free Cash Flow (TTM) | ₹1.36B | ₹1.08B |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.54% | 0.64% |
| Last 12-Month Dividend | ₹43.78 | ₹1.60 |
Valuation & Enterprise Metrics Analysis: Rossari Biotech Ltd. vs Fineotex Chemical Ltd.
| Metric | ROSSARI (Apr 26, 2026) | FCL (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 20.79 | 26.19 |
| Forward P/E | 17.98 | 20.95 |
| PEG Ratio | -2.83 | -0.29 |
| Price to Sales (TTM) | 1.25 | 4.64 |
| Price to Book (MRQ) | 2.28 | 3.39 |
| Market Capitalization | ||
| Market Capitalization | ₹28.60B | ₹27.02B |
| Enterprise Value | ₹31.35B | ₹26.07B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.37 | 4.51 |
| Enterprise to EBITDA | 12.22 | 22.94 |
| Risk & Other Metrics | ||
| Beta | 0.33 | 0.05 |
| Book Value per Share (MRQ) | ₹226.03 | ₹6.81 |
Financial Statements Comparison: Rossari Biotech Ltd. vs Fineotex Chemical Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | ROSSARI (2025) | FCL (2025) |
|---|---|---|
| Revenue/Sales | 20.71B | 5.32B |
| Cost of Goods Sold | 14.50B | 3.30B |
| COGS % of Revenue | 70.0% | 62.0% |
| Gross Profit | 6.22B | 2.02B |
| Gross Margin | 30.0% | 38.0% |
| Research & Development | N/A | 8.98M |
| Operating Income (EBIT) | 1.87B | 1.19B |
| Operating Margin | 9.0% | 22.3% |
| EBITDA | 2.68B | 1.32B |
| EBITDA Margin | 13.0% | 24.8% |
| Pre-Tax Income | 1.85B | 1.41B |
| Pre-Tax Income % of Revenue | 8.9% | 26.6% |
| Income Tax | 488.07M | 320.35M |
| Income Tax % of Revenue | 2.4% | 6.0% |
| Net Income (Profit) | 1.36B | 1.09B |
| Profit Margin | 6.6% | 20.5% |
Balance Sheet & Liquidity Metrics
| Metric | ROSSARI (2025) | FCL (2025) |
|---|---|---|
| Cash & Equivalents | 442.02M | 292.90M |
| Total Current Assets | 10.42B | 2.61B |
| Total Current Assets % of Revenue | 50.3% | 49.1% |
| Total Current Liabilities | 5.37B | 671.02M |
| Total Current Liabilities % of Revenue | 25.9% | 12.6% |
| Long-Term Debt | 1.22B | N/A |
| Long-Term Debt % of Revenue | 5.9% | 0.0% |
| Total Shareholders Equity | 11.85B | 7.39B |
| Retained Earnings | 6.97B | 5.29B |
| Retained Earnings % of Revenue | 33.7% | 99.5% |
| Property, Plant & Equipment | 0 | 1.73B |
Cash Flow Statement Comparison
| Metric | ROSSARI (2025) | FCL (2025) |
|---|---|---|
| Operating Cash Flow | 440.09M | 1.05B |
| Operating Cash Flow % of Revenue | 2.1% | 19.7% |
| Capital Expenditures | -1.58B | -675.77M |
| Free Cash Flow | -210.69M | 17.57M |
| FCF Margin | -1.0% | 0.3% |
| Debt Repayment | -385.79M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ROSSARI | FCL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 55.38M | 1.16B |
| Float Shares | 17.63M | 393.28M |
| % Held by Insiders | 68.15% | 67.86% |
| % Held by Institutions | 18.64% | 1.54% |
| % Held by Public | 13.21% | 30.60% |
Dividend Analysis & Yield Comparison: Rossari Biotech Ltd. vs Fineotex Chemical Ltd.
| Metric | ROSSARI | FCL |
|---|---|---|
| Last 12-Month Dividend | ₹43.78 | ₹1.60 |
| Last 12-Month Dividend Yield | 6.54% | 0.64% |
| 3-Year Avg Annual Dividend | ₹14.93 | ₹1.33 |
| 3-Year Avg Dividend Yield | 1.66% | 0.21% |
| 3-Year Total Dividends | ₹44.78 | ₹4.00 |
| Ex-Dividend Date | Jun 20, 2025 | Oct 03, 2025 |